Angiologie : ce qui a changé en 2025

View at publisher
Authors: Abdelwahab Boulekbache, Marc Righini
Cited by: 0

Abstract

In 2025, three major prospective studies shaped the field of venous thromboembolism (VTE) in angiological practice. The ADJUST-DVT study aimed to validate the use of age-adjusted D-dimer thresholds to diagnose deep vein thrombosis, following the already-established strategy for pulmonary embolism. The COBRRA trial was the first prospective study to compare the safety and efficacy of apixaban versus rivaroxaban in the treatment of acute VTE. Finally, the API-CAT study investigated extended anticoagulation in cancer-associated VTE, assessing the long-term use of reduced-dose apixaban as an alternative to full-dose therapy to minimize the risk of bleeding.

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Atrial Fibrillation Management and Outcomes

Publication details

Journal / source
JMIG
Volume
22
Issue
945
Pages
15–18
Publication date
1 January 2026
Language
EN